RxDoctor Payments Data

Guillermo Bernal, MD

Physical Medicine & Rehabilitation · Newtown, PANPI 1912904137

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), other and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Cadwell Industries, Inc at 41.5% of the total. Reporting peaked in 2024 at $3,098 and has fallen 58.1% since, to $1,297 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,204in general payments, 2019–2025

Across 94 payments — averaging $66.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cadwell Industries, Inc$3K
  • AbbVie$1K
  • Nevro Corp.$655
  • Electronic Waveform Lab, Inc.$292
  • Globus Medical$281
  • Pfizer$208
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,57558%
  • Education$531%
  • Other$2,57642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cadwell Industries, Inc1$2,576
AbbVie(2 entities)44$1,149
Nevro Corp.7$655
Electronic Waveform Lab, Inc.3$292
Globus Medical2$281
Pfizer9$208
Stryker2$146
Merz North America, Inc.5$146
Ipsen Biopharmaceuticals, Inc3$144
Axsome Therapeutics, Inc.1$125
Boston Scientific2$124
Merz Pharmaceuticals, LLC3$97
Si-bone, Inc.2$96
Biodelivery Sciences International, Inc.6$76
Zimmer Biomet1$37
Abbott1$25
Bioventus LLC1$13
Medtronic1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,204 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$205,993
Medicare patients
287
Services billed
18,060

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl72$93,758
PercocetOxycodone Hcl/Acetaminophen11$53,492
QuliptaAtogepant15$16,240
Fentanyl65$7,165
Oxycodone Hcl194$4,809
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$3,800
Gabapentin224$3,135
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen66$2,810
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen117$2,684
Dimethyl Fumarate12$2,282
Lidocaine11$1,975
Tramadol Hcl ErTramadol Hcl26$1,176
Baclofen37$916
Duloxetine Hcl67$823
Diazepam55$767

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta$1,149$16,24015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

Other physical medicine & rehabilitation in Newtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →